[A meta-analysis of treatment of infantile diarrhea with bifid triple viable bacterial tablet]
- PMID: 16053735
[A meta-analysis of treatment of infantile diarrhea with bifid triple viable bacterial tablet]
Abstract
Objective: To assess the efficacy and safety of bifid triple viable bacterial tablet in treatment of infantile diarrhea.
Methods: According to the requirements of Cochrane systematic review, a thorough literature search was performed among Chinese Digital Hospital Library (www.chkd.cnki.net) and Chinese Biomedical Literature Disk Database (CBMdisk). A meta analysis was performed on a total of 1326 patients involved in 12 papers which met the inclusion criteria.
Results: Publication bias analysis showed that the funnel plot was symmetrical. Test for heterogeneity showed that the groups treated with bifid triple viable bacterial tablet and antibiotics or anti-viral agents or placebo control had clinical homogeneity and statistical homogeneity (P = 0.66, 0.67, 0.85, respectively, I(2) = 0%), which allowed to use fixed effect model analysis. The bifid triple viable bacterial tablet and Smecta did not have statistical homogeneity (P = 0.02, I(2) = 70.9%), therefore random effect model analysis was applied. Incorporation analysis showed that in comparison of the bifid triple viable bacterial tablet versus antibiotics or anti-viral agents or placebo control, the odds ratios were 5.34, 4.74 and 6.43, respectively, and 95% CIs were [2.81, 10.16], [2.47, 9.09], and [2.61, 15.83], on test for overall effect, Z = 5.11, 4.67 and 4.04, P < 0.00001. In the forest plot the 95% CI horizontal line of incorporation odds ratio droped to the right side of the vertical line indicating the border of effectiveness. However, no statistically significant difference was found between bifid triple viable bacterial tablet and Smecta.
Conclusion: The clinical evidences available so far indicated that treatment of infantile diarrhea with bifid triple viable bacterial tablet is safe and effective although rigorously designed large sample size randomized double blind clinical trials are required to further demonstrate and support the conclusion.
Similar articles
-
[Meta analysis of effectiveness of acupoint application therapy for infantile diarrhea].Zhen Ci Yan Jiu. 2013 Aug;38(4):319-23. Zhen Ci Yan Jiu. 2013. PMID: 24261304 Review. Chinese.
-
Meta-analysis of the effects of Bifidobacterium preparations for the prevention and treatment of pediatric antibiotic-associated diarrhea in China.Complement Ther Med. 2017 Aug;33:105-113. doi: 10.1016/j.ctim.2017.07.001. Epub 2017 Jul 6. Complement Ther Med. 2017. PMID: 28735819
-
Bifid triple viable preparation combined with enteral nutrition as a supportive treatment for acute ischemic stroke: a systematic review and meta-analysis.Front Microbiol. 2024 Jul 10;15:1408960. doi: 10.3389/fmicb.2024.1408960. eCollection 2024. Front Microbiol. 2024. PMID: 39050623 Free PMC article.
-
[A multicenter randomized parallel-controlled study on the efficacy and safety of er xie ting granules in children with acute diarrhea].Zhonghua Er Ke Za Zhi. 2013 Sep;51(9):670-5. Zhonghua Er Ke Za Zhi. 2013. PMID: 24330986 Clinical Trial. Chinese.
-
Traditional Chinese Medicine Moxibustion in the Treatment of Infantile Diarrhea.Comput Intell Neurosci. 2022 Jun 30;2022:9749606. doi: 10.1155/2022/9749606. eCollection 2022. Comput Intell Neurosci. 2022. Retraction in: Comput Intell Neurosci. 2023 Dec 13;2023:9872659. doi: 10.1155/2023/9872659. PMID: 35814536 Free PMC article. Retracted.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous